COO

CooperVision momentum and MyDay/MiSight adoption are likely to fuel COO's Q2, but Japan softness and fertility uncertainty remain key watch points.

EYE is pairing smart-glasses expansion, premium upgrades and military growth as it targets higher tickets and margin gains in 2026.

Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Thursday after the bell. Here’s what investors should know.

Recent performance snapshot Cooper Companies (COO) has drawn investor attention after a stretch of weaker share performance, with the stock down 2% over the past month and about 27% over the past 3 months. See our latest analysis for Cooper Companies. At a share price of US$61.21, Cooper Companies has seen short term share price momentum soften. The 7 day share price return is down 2.14% and the 90 day share price return is down 26.58%, while the 1 year total shareholder return declined...

Beyond analysts' top-and-bottom-line estimates for The Cooper Companies (COO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2026.

Piper Sandler analyst Jason Bednar reiterates Cooper Companies (NASDAQ:COO) with a Overweight and lowers the price target from $94 to $86.